ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION AND CHRONIC ISCHEMIC HEART DISEASE

被引：1
|
作者：
Rychkov, A. Yu [1 ]
Khorkova, N. Yu [1 ]
机构：
[1] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Tomsk, Russia
来源：
KARDIOLOGIYA | 2019年 / 59卷 / 05期
关键词：
atrial fibrillation; ischemic heart disease; oral anticoagulants; PERCUTANEOUS CORONARY INTERVENTION; DUAL ANTIPLATELET THERAPY; VITAMIN-K ANTAGONIST; ORAL ANTICOAGULATION; ARTERY-DISEASE; ESC GUIDELINES; VS; PLACEBO; OPEN-LABEL; ASPIRIN; WARFARIN;
D O I：
10.18087/cardio.2019.5.n493
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The review is devoted to the use of antithrombotic therapy in patients with atrial fibrillation (AF) and chronic ischemic heart disease (IHD). We discuss data of international registries, meta-analyses assessing possibilities of the use of oral anticoagulants for secondary prevention of IHD. We present here results of randomized and observational clinical studies demonstrating advantages of prescription of monotherapy with oral anticoagulants (OAC) in combination of AF and chronic IHD. Modern evidence base of advantages of dual antithrombotic therapy with the use of direct OAC following percutaneous coronary intervention is also presented.
引用
收藏
页码：80 / 86
页数：7
相关论文
共 50 条
  • [1] The antithrombotic therapy of atrial fibrillation in patients with coronary heart disease
    Bockeria, Olga L.
    Le, Tatyana G.
    RUSSIAN OPEN MEDICAL JOURNAL, 2018, 7 (04)
  • [2] Antithrombotic Therapy for Atrial Fibrillation and stable coronary Heart Disease
    Dovjak, Peter
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2019, 52 (08): : 808 - 809
  • [3] Antithrombotic therapy in patients with combined coronary heart disease and atrial fibrillation
    Thompson, Peter L.
    Morton, Allison C.
    PANMINERVA MEDICA, 2016, 58 (01) : 23 - 33
  • [4] Prior Antithrombotic Therapy is Associated with Cerebral Microbleeds in Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease
    Cheng, Yajun
    Liu, Junfeng
    Zhang, Shuting
    Li, Jie
    Wei, Chenchen
    Wang, Yanan
    Liu, Ming
    NEUROLOGY, 2019, 92 (15)
  • [5] Prior Antithrombotic Therapy Is Associated With Cerebral Microbleeds in Ischemic Stroke Patients With Atrial Fibrillation and/or Rheumatic Heart Disease
    Cheng, Yajun
    Liu, Junfeng
    Zhang, Shuting
    Lie, Jie
    Wei, Chenchen
    Wang, Deren
    Lin, Jing
    Wang, Yanan
    Wu, Bo
    Zhang, Shihong
    Liu, Ming
    FRONTIERS IN NEUROLOGY, 2019, 9
  • [6] Managing Antithrombotic Therapy in Patients With Both Atrial Fibrillation and Coronary Heart Disease
    Thompson, Peter L.
    Verheugt, Freek W. A.
    CLINICAL THERAPEUTICS, 2014, 36 (09) : 1176 - 1181
  • [7] The risks and benefits of antithrombotic therapy in chronic atrial fibrillation
    Hankey, GJ
    Gray, NJ
    MEDICAL JOURNAL OF AUSTRALIA, 1996, 164 (10) : 624 - 626
  • [8] Prior antithrombotic therapy is associated with cerebral microbleeds but not leukoaraiosis in ischemic stroke patients with atrial fibrillation and/or rheumatic heart disease
    Cheng, Y.
    Liu, J.
    Zhang, S.
    Li, J.
    Wei, C.
    Wang, Y.
    Liu, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [9] Prognostic impact of a history of cancer and atrial fibrillation in antithrombotic therapy for chronic heart failure
    Nochioka, Kotaro
    Yasuda, Satoshi
    Sakata, Yasuhiko
    Shiroto, Takashi
    Hayashi, Hideka
    Takahashi, Jun
    Takahama, Hiroyuki
    Miyata, Satoshi
    Shimokawa, Hiroaki
    ESC HEART FAILURE, 2022, 9 (04): : 2445 - 2454
  • [10] Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
    Gremmel, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25): : 2480 - 2481
12345